Carmot

Berkeley, United States Founded: 2008 • Age: 18 yrs Acquired By Roche
Disease-modifying therapies for metabolic diseases are developed.
Request Access

About Carmot

Carmot is a company based in Berkeley (United States) founded in 2008 was acquired by Roche in December 2023.. Carmot has raised $385.52 million across 17 funding rounds from investors including Amgen, Roche and HHS. Carmot operates in a competitive market with competitors including Adocia, Altimmune, BioAge Labs, Fractyl and Antag Therapeutics, among others.

  • Headquarter Berkeley, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Carmot Therapeutics Inc
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $385.52 M (USD)

    in 17 rounds

  • Latest Funding Round
    $150 M (USD), Series E

    May 25, 2023

  • Investors
    Amgen

    & 18 more

  • Employee Count
    Employee Count
  • Acquired by
    Roche

    (Dec 04, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Carmot

Carmot has successfully raised a total of $385.52M across 17 strategic funding rounds. The most recent funding activity was a Series E round of $150 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 17
  • Last Round Series E — $150.0M
  • First Round

    (22 Oct 2009)

  • Investors Count 19
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2023 Amount Series E - Carmot Valuation Deep Track Capital
Jul, 2022 Amount Series D - Carmot Valuation TCG
Sep, 2020 Amount Series C - Carmot Valuation Amgen
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Carmot

Carmot has secured backing from 19 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Amgen, Roche and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Deep Track Capital is engaged in biotechnology investment activities.
Founded Year Domain Location
Venture capital fund backed incubator focused on the healthcare startups
Founded Year Domain Location
Healthcare sector private equity investments are managed by the firm.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Carmot

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Carmot

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Carmot Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Carmot

Carmot operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adocia, Altimmune, BioAge Labs, Fractyl and Antag Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapeutics for diabetes and obesity treatment are developed.
domain founded_year HQ Location
Vaccines for infectious diseases and solid tumors are developed.
domain founded_year HQ Location
Bioinformatics platform is provided for biomarkers and drug discovery.
domain founded_year HQ Location
Endoscopic procedures for type-2 diabetes treatment are developed.
domain founded_year HQ Location
Peptide-based therapies for obesity and cardiometabolic disorders are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Carmot

Frequently Asked Questions about Carmot

When was Carmot founded?

Carmot was founded in 2008 and raised its 1st funding round 1 year after it was founded.

Where is Carmot located?

Carmot is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.

Who is the current CEO of Carmot?

Heather Turner is the current CEO of Carmot.

Is Carmot a funded company?

Carmot is a funded company, having raised a total of $385.52M across 17 funding rounds to date. The company's 1st funding round was a Series C of $47M, raised on Oct 22, 2009.

What does Carmot do?

The company was founded in 2008 in Berkeley, United States, and focuses on biotechnology for metabolic disorders. A drug discovery platform is utilized to identify incretin receptor signaling targets, supporting a pipeline of therapeutics aimed at obesity and diabetes. Three clinical candidatesCT-388, CT-868, and CT-996are advanced through development stages. Operations center on innovative treatments without emphasis on broader services.

Who are the top competitors of Carmot?

Carmot's top competitors include Adocia, BioAge Labs and Fractyl.

Who are Carmot's investors?

Carmot has 19 investors. Key investors include Amgen, Roche, HHS, Schroders, and Janus Henderson Investors.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available